Want to join the conversation?
$VRTX has exclusively licensed VX-210 to treat acute spinal cord injury from BioAxone BioSciences. VX-210 is designed to inhibit protein known as Rho that blocks neural regeneration after injury. $VRTX will start Phase 2b/3 clinical trial in 1H16 to evaluate efficacy and safety of VX-210 in patients with certain acute cervical spinal cord injuries.
Planned to give Apple AirPods as a Christmas present to my beloved one. Looks like I need backup plans as $AAPL is delaying the release..!!
When you fall hard, I think you stay there for a long time.. I am looking at you $FTNT! After it released the earnings, the share price slipped and is staying around $30 for a long time.
$FOXA just entered into a preliminary deal with Sky plc under which it will acquire all shares, or should I say remaining shares for a total value of $23 billion. The sleeping fox catches no poultry, but this fox just caught something that’s a lot bigger than poultry.